Conventional proliferation markers such as Ki-67 and proliferation cell nuclear antigen (PCNA) are the most largely used proliferation markers in diagnosis of several human malignancies such as breast tumors, sarcoma in soft tissues, meningioma, malignancies of prostate, and non-Hodgkin lymphoma.[1-4]. This evidence concerns the gene PCNA and non-Hodgkin lymphoma.